Surgalign Holdings Management
Management criteria checks 3/4
Surgalign Holdings' CEO is Terry Rich, appointed in Jul 2020, has a tenure of 3.25 years. total yearly compensation is $1.21M, comprised of 45.5% salary and 54.5% bonuses, including company stock and options. directly owns 1.3% of the company’s shares, worth $2.15K. The average tenure of the management team and the board of directors is 2.1 years and 4.9 years respectively.
Key information
Terry Rich
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 45.5% |
| CEO tenure | 3.3yrs |
| CEO ownership | 1.3% |
| Management average tenure | 2.1yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
Surgalign stock rises 7% after receiving FDA clearance of Cortera spinal fixation system
Aug 24Surgalign revenue of $20.62M misses by $0.51M, reconfirms full-year revenue
Aug 09Surgalign Holdings - A Future Of Digital Surgery
Dec 21Sizing Up Surgalign
Sep 23Surgalign Holdings: Insiders Are Buying
Aug 28Surgalign Holdings: Pinocchio Has A Happy Ending
Aug 10Surgalign Holdings: A Marketing Ploy
Jun 29Surgalign reports inducement grants under Nasdaq listing rule
Jun 04Have Insiders Been Buying Surgalign Holdings, Inc. (NASDAQ:SRGA) Shares?
Mar 08
Surgalign Holdings : Strong Upside Potential
Jan 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -US$50m |
| Dec 31 2022 | US$1m | US$550k | -US$55m |
| Sep 30 2022 | n/a | n/a | -US$62m |
| Jun 30 2022 | n/a | n/a | -US$61m |
| Mar 31 2022 | n/a | n/a | -US$66m |
| Dec 31 2021 | US$2m | US$544k | -US$81m |
| Sep 30 2021 | n/a | n/a | -US$152m |
| Jun 30 2021 | n/a | n/a | -US$171m |
| Mar 31 2021 | n/a | n/a | -US$185m |
| Dec 31 2020 | US$2m | US$467k | -US$194m |
Compensation vs Market: Terry's total compensation ($USD1.21M) is above average for companies of similar size in the US market ($USD740.57K).
Compensation vs Earnings: Terry's compensation has been consistent with company performance over the past year.
CEO
Terry Rich (55 yo)
3.3yrs
Tenure
US$1,209,086
Compensation
Mr. Terry M. Rich has been President, Chief Executive Officer and Director of Surgalign Holdings, Inc. since July 2020. He joined Surgalign in November 2019. He was President of Global Spine at Surgalign H...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.3yrs | US$1.21m | 1.3% $ 2.2k | |
| Chief Financial Officer | 1.6yrs | US$1.04m | 0.47% $ 775.3 | |
| VP & Chief Accounting Officer | 2.1yrs | US$458.76k | 0.18% $ 290.2 | |
| Chief Legal Officer | 1.2yrs | no data | 0.12% $ 194.6 | |
| Chief People Officer | 1.8yrs | no data | no data | |
| Executive Vice President of International | 3.3yrs | US$573.81k | 0.13% $ 217.4 | |
| Executive Vice President of Digital Surgery | 2.5yrs | no data | 0.29% $ 478.0 | |
| Executive Vice President of Research and Clinical Affairs | no data | no data | no data |
2.1yrs
Average Tenure
54.5yo
Average Age
Experienced Management: SRGA.Q's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.3yrs | US$1.21m | 1.3% $ 2.2k | |
| Independent Director | 7.3yrs | US$142.50k | 0.31% $ 515.0 | |
| Independent Chair of the Board | 2.4yrs | US$189.47k | 0.021% $ 34.7 | |
| Independent Director | 6.6yrs | US$157.50k | 0.31% $ 519.6 | |
| Independent Director | 7.3yrs | US$150.00k | 0.34% $ 554.6 | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 7.8yrs | US$150.00k | 0.32% $ 533.0 | |
| Independent Director | less than a year | no data | no data |
4.9yrs
Average Tenure
62yo
Average Age
Experienced Board: SRGA.Q's board of directors are considered experienced (4.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/04 22:47 |
| End of Day Share Price | 2023/10/02 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Surgalign Holdings, Inc. is covered by 14 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Raymond Myers | Benchmark Company |
| Michael Gorman | BTIG |
| William Plovanic | Canaccord Genuity |